Humoral and B-cell memory responses in children five years after pertussis acellular vaccine priming

Vaccine

Volumn 32, Issue 18, 2014, Pages 2093-2099

  Carollo, Maria ^a   Pandolfi, Elisabetta ^b   Tozzi, Alberto Eugenio ^b   Buisman, Anne Marie ^c   Mascart, Françoise ^d   Ausiello, Clara Maria ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d ERASME HOSPITAL   (Belgium)

Author keywords

Antibodies; Booster vaccination; Children; Memory B cell immune response; Pertussis; Vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN G; PERTACTIN; PERTUSSIS VACCINE;

ARTICLE; BLOOD SAMPLING; CHILD; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MEMORY CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; VACCINATION;

ANTIBODIES; BOOSTER VACCINATION; CHILDREN; MEMORY B-CELL IMMUNE RESPONSE; PERTUSSIS; VACCINATION;

ANTIBODIES, BACTERIAL; B-LYMPHOCYTES; CHILD; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; MALE; POLIOVIRUS VACCINE, INACTIVATED; WHOOPING COUGH;

EID: 84896544462     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.02.005     Document Type: Article

References (37)

1. Zepp F., Heininger U., Mertsola J., Bernatowska E., Guiso N., Roord J., et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011, 11:557-570.
2. Cherry J.D. Epidemic pertussis in 2012. The resurgence of a vaccine-preventable disease. N Engl J Med 2012, 367:785-787.
3. Klein N.P., Bartlett J., Rowhani-Rahbar A., Fireman B., Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med 2012, 367:1012-1019.
4. Jefferson T., Rudin M., DiPietrantonj C. Systematic review of the effects of pertussis vaccines in children. Vaccine 2003, 21:2003-2014.
5. Gustafsson L., Hessel L., Storsaeter J., Olin P. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Pediatrics 2006, 118:978-984.
6. Hallander H.O., Andersson M., Gustafsson L., Ljungman M., Netterlid E. Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program. APMIS 2009, 117:912-922.
7. Quinn H.E., McIntyre P.B., Backhouse J.L., Gidding H.F., Brotherton J., Gilbert G.L. The utility of seroepidemiology for tracking trends in pertussis infection. Epidemiol Infect 2010, 138:426-433.
8. de Greeff S.C., Mooi F.R., Westerhof A., Verbakel J.M., Peeters M.F., Heuvelman C.J., et al. Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis 2010, 50:1339-1345.
9. Storsaeter J., Hallander H.O., Gustafsson L., Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998, 16:1907-1916.
10. Cherry J.D., Gornbein J., Heininger U., Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998, 16:1901-1906.
11. Edelman K., He Q., Mäkinen J., Sahlberg A., Haanperä M., Schuerman L., et al. Immunity to pertussis 5 years after booster immunization during adolescence. Clin Infect Dis 2007, 44:1271-1277.
12. Riffelmann M., Littmann M., Hülsse C., Wirsing von König C.H. Antibody decay after immunisation of health-care workers with an acellular pertussis vaccine. Eur J Clin Microbiol Infect Dis 2009, 28:275-279.
13. Hallander H.O., Gustafsson L., Ljungman M., Storsaeter J. Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose. Vaccine 2005, 23:5359-5364.
14. Giuliano M., Mastrantonio P., Giammanco A., Piscitelli A., Salmaso S., Wassilak S.G. Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. J Pediatr 1998, 132:983-988.
15. Cassone A., Ausiello C.M., Urbani F., Lande R., Giuliano M., La Sala A., et al. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group. Arch Pediatr Adolesc Med 1997, 151:283-289.
16. Hendrikx L.H., de Rond L.G., Oztürk K., Veenhoven R.H., Sanders E.A., Berbers G.A., et al. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age. Vaccine 2011, 29:5725-5730.
17. Hendrikx L.H., Felderhof M.K., Oztürk K., de Rond L.G., van Houten M.A., Sanders E.A., et al. Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age. Vaccine 2011, 30:51-58.
18. Schure R.M., Hendrikx L.H., de Rond L.G., Oztürk K., Sanders E.A., Berbers G.A., et al. Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination. Clin Vaccine Immunol 2013, 20:1388-1395.
19. Carollo M., Palazzo R., Bianco M., Smits K., Mascart F., Ausiello C.M. Antigen-specific responses assessment for the evaluation of Bordetella pertussis T cell immunity in humans. Vaccine 2012, 21:1667-1674.
20. Smits K., Pottier G., Smet J., Dirix V., Vermeulen F., De Schutter I., et al. Different T cell memory in preadolescents after whole-cell or acellular vaccination. Vaccine 2013, 32:111-118.
21. Bernasconi N.L., Traggiai E., Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002, 298:2199-2202.
22. Zanetti A.R., Romanò L., Giambi C., Pavan A., Carnelli V., Baitelli G., et al. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study. Lancet Infect Dis 2010, 10:755-761.
23. Nasso M., Fedele G., Spensieri F., Palazzo R., Costantino P., Rappuoli R., et al. Genetically detoxified pertussis toxin induces Th1/Th17 immune response through MAPKs and IL-10-dependent mechanisms. J Immunol 2009, 183:1892-1899.
24. Hijnen M., van Gageldonk P.G., Berbers G.A., van Woerkom T., Mooi F.R. The Bordetella pertussis virulence factor P.69 pertactin retains its immunological properties after overproduction in Escherichia coli. Protein Expr Purif 2005, 41:106-112.
25. van Gageldonk P.G., van Schaijk F.G., van der Klis F.R., Berbers G.A. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. J Immunol Methods 2008, 335:79-89.
26. Long S.S., Welkon C.J., Clark J.L. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis 1990, 161:480-486.
27. Tomovici A., Barreto L., Zickler P., Meekison W., Noya F., Voloshen T., et al. Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine 2012, 30:2647-2653.
28. Versteegh F.G., Mertens P.L., deMelker H.E., Roord J.J., Schellekens J.F., Teunis P.F. Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiol Infect 2005, 133:737-748.
29. Guiso N., Berbers G., Fry N.K., He Q., Riffelmann M., Wirsing von König C.H. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 2011, 30:307-312.
30. Wiedermann B.L. What's wrong with acellular pertussis vaccines. Clin Ther 2013, 35:115-118.
31. Witt M.A., Katz P.H., Witt D.J. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis 2012, 54:1730-1735.
32. Gabutti G., Rota M.C. Pertussis: a review of disease epidemiology worldwide and in Italy. Int J Environ Res Public Health 2012, 9:4626-4638.
33. Morel S., Denoël P., Godfroid F., Cortvrindt C., Vanderheyde N., Poolman J. Induction of Bordetella pertussis-specific immune memory by DTPa vaccines. Vaccine 2011, 29:3449-3455.
34. Denoël P., Poolman J., Carletti G., Veitch K. Effects of adsorption of acellular pertussis antigens onto different aluminium salts on the protective activity in an intranasal murine model of Bordetella pertussis infection. Vaccine 2002, 20:2551-2555.
35. Rosado M.M., Scarsella M., Pandolfi E., Cascioli S., Giorda E., Chionne P., et al. Switched memory B cells maintain specific memory independently of serum antibodies: the hepatitis B example. Eur J Immunol 2011, 41:1800-1808.
36. Carollo M., Palazzo R., Bianco M., Pandolfi E., Chionne P., Fedele G., et al. Hepatitis B specific T cell immunity induced by primary vaccination persists independently of the protective serum antibody level. Vaccine 2013, 31:506-513.
37. Libster R., Edwards K.M. Re-emergence of pertussis: what are the solutions. Expert Rev Vaccines 2012, 11:1331-1346.